United States Liposomes Drug Delivery Market Report 2017

Publisher Name :
Date: 22-Nov-2017
No. of pages: 107
Inquire Before Buying

In this report, the United States Liposomes Drug Delivery market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

- The West

- Southwest

- The Middle Atlantic

- New England

- The South

- The Midwest

with sales (volume), revenue (value), market share and growth rate of Liposomes Drug Delivery in these regions, from 2012 to 2022 (forecast).

United States Liposomes Drug Delivery market competition by top manufacturers/players, with Liposomes Drug Delivery sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

- Johnson & Johnson

- Gilead Sciences

- Luye Pharma

- Sun Pharmaceutical

- Pacira

- Fudan-Zhangjiang

- Sigma-Tau Group

- Teva Pharmaceutical

- CSPC

- Novartis

- Crucell

- Celsion Corporation

- Kingond Pharm

- Shanghai New Asia

- Spectrum Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Type I

- Type II

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

- Fungal Infection Therapy

- Cancer Therapy

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Liposomes Drug Delivery Market Report 2017

Table of Contents
United States Liposomes Drug Delivery Market Report 2017
1 Liposomes Drug Delivery Overview
1.1 Product Overview and Scope of Liposomes Drug Delivery
1.2 Classification of Liposomes Drug Delivery by Product Category
1.2.1 United States Liposomes Drug Delivery Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Liposomes Drug Delivery Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3
1.2.4
1.3 United States Liposomes Drug Delivery Market by Application/End Users
1.3.1 United States Liposomes Drug Delivery Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Fungal Infection Therapy
1.3.3 Cancer Therapy
1.4 United States Liposomes Drug Delivery Market by Region
1.4.1 United States Liposomes Drug Delivery Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Liposomes Drug Delivery Status and Prospect (2012-2022)
1.4.3 Southwest Liposomes Drug Delivery Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Liposomes Drug Delivery Status and Prospect (2012-2022)
1.4.5 New England Liposomes Drug Delivery Status and Prospect (2012-2022)
1.4.6 The South Liposomes Drug Delivery Status and Prospect (2012-2022)
1.4.7 The Midwest Liposomes Drug Delivery Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Liposomes Drug Delivery (2012-2022)
1.5.1 United States Liposomes Drug Delivery Sales and Growth Rate (2012-2022)
1.5.2 United States Liposomes Drug Delivery Revenue and Growth Rate (2012-2022)
2 United States Liposomes Drug Delivery Market Competition by Players/Suppliers
2.1 United States Liposomes Drug Delivery Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Liposomes Drug Delivery Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Liposomes Drug Delivery Average Price by Players/Suppliers (2012-2017)
2.4 United States Liposomes Drug Delivery Market Competitive Situation and Trends
2.4.1 United States Liposomes Drug Delivery Market Concentration Rate
2.4.2 United States Liposomes Drug Delivery Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Liposomes Drug Delivery Manufacturing Base Distribution, Sales Area, Product Type
3 United States Liposomes Drug Delivery Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Liposomes Drug Delivery Sales and Market Share by Region (2012-2017)
3.2 United States Liposomes Drug Delivery Revenue and Market Share by Region (2012-2017)
3.3 United States Liposomes Drug Delivery Price by Region (2012-2017)
4 United States Liposomes Drug Delivery Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Liposomes Drug Delivery Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Liposomes Drug Delivery Revenue and Market Share by Type (2012-2017)
4.3 United States Liposomes Drug Delivery Price by Type (2012-2017)
4.4 United States Liposomes Drug Delivery Sales Growth Rate by Type (2012-2017)
5 United States Liposomes Drug Delivery Sales (Volume) by Application (2012-2017)
5.1 United States Liposomes Drug Delivery Sales and Market Share by Application (2012-2017)
5.2 United States Liposomes Drug Delivery Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Liposomes Drug Delivery Players/Suppliers Profiles and Sales Data
6.1 Johnson & Johnson
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Liposomes Drug Delivery Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Johnson & Johnson Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Gilead Sciences
6.2.2 Liposomes Drug Delivery Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Gilead Sciences Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Luye Pharma
6.3.2 Liposomes Drug Delivery Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Luye Pharma Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Sun Pharmaceutical
6.4.2 Liposomes Drug Delivery Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Sun Pharmaceutical Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Pacira
6.5.2 Liposomes Drug Delivery Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Pacira Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Fudan-Zhangjiang
6.6.2 Liposomes Drug Delivery Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Fudan-Zhangjiang Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Sigma-Tau Group
6.7.2 Liposomes Drug Delivery Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Sigma-Tau Group Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Teva Pharmaceutical
6.8.2 Liposomes Drug Delivery Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Teva Pharmaceutical Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 CSPC
6.9.2 Liposomes Drug Delivery Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 CSPC Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Novartis
6.10.2 Liposomes Drug Delivery Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Novartis Liposomes Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Crucell
6.12 Celsion Corporation
6.13 Kingond Pharm
6.14 Shanghai New Asia
6.15 Spectrum Pharmaceuticals
7 Liposomes Drug Delivery Manufacturing Cost Analysis
7.1 Liposomes Drug Delivery Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Liposomes Drug Delivery
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Liposomes Drug Delivery Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Liposomes Drug Delivery Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Liposomes Drug Delivery Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Liposomes Drug Delivery Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Liposomes Drug Delivery Sales Volume Forecast by Type (2017-2022)
11.3 United States Liposomes Drug Delivery Sales Volume Forecast by Application (2017-2022)
11.4 United States Liposomes Drug Delivery Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Liposomes Drug Delivery
Figure United States Liposomes Drug Delivery Market Size (K Units) by Type (2012-2022)
Figure United States Liposomes Drug Delivery Sales Volume Market Share by Type (Product Category) in 2016
Figure Type I Product Picture
Figure Type II Product Picture
Figure United States Liposomes Drug Delivery Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Liposomes Drug Delivery by Application in 2016
Figure Fungal Infection Therapy Examples
Table Key Downstream Customer in Fungal Infection Therapy
Figure Cancer Therapy Examples
Table Key Downstream Customer in Cancer Therapy
Figure United States Liposomes Drug Delivery Market Size (Million USD) by Region (2012-2022)
Figure The West Liposomes Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Liposomes Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Liposomes Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Liposomes Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Liposomes Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Liposomes Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Liposomes Drug Delivery Sales (K Units) and Growth Rate (2012-2022)
Figure United States Liposomes Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Liposomes Drug Delivery Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Liposomes Drug Delivery Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Liposomes Drug Delivery Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Liposomes Drug Delivery Sales Share by Players/Suppliers
Figure 2017 United States Liposomes Drug Delivery Sales Share by Players/Suppliers
Figure United States Liposomes Drug Delivery Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Liposomes Drug Delivery Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Liposomes Drug Delivery Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Liposomes Drug Delivery Revenue Share by Players/Suppliers
Figure 2017 United States Liposomes Drug Delivery Revenue Share by Players/Suppliers
Table United States Market Liposomes Drug Delivery Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Liposomes Drug Delivery Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Liposomes Drug Delivery Market Share of Top 3 Players/Suppliers
Figure United States Liposomes Drug Delivery Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Liposomes Drug Delivery Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Liposomes Drug Delivery Product Category
Table United States Liposomes Drug Delivery Sales (K Units) by Region (2012-2017)
Table United States Liposomes Drug Delivery Sales Share by Region (2012-2017)
Figure United States Liposomes Drug Delivery Sales Share by Region (2012-2017)
Figure United States Liposomes Drug Delivery Sales Market Share by Region in 2016
Table United States Liposomes Drug Delivery Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Liposomes Drug Delivery Revenue Share by Region (2012-2017)
Figure United States Liposomes Drug Delivery Revenue Market Share by Region (2012-2017)
Figure United States Liposomes Drug Delivery Revenue Market Share by Region in 2016
Table United States Liposomes Drug Delivery Price (USD/Unit) by Region (2012-2017)
Table United States Liposomes Drug Delivery Sales (K Units) by Type (2012-2017)
Table United States Liposomes Drug Delivery Sales Share by Type (2012-2017)
Figure United States Liposomes Drug Delivery Sales Share by Type (2012-2017)
Figure United States Liposomes Drug Delivery Sales Market Share by Type in 2016
Table United States Liposomes Drug Delivery Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Liposomes Drug Delivery Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Liposomes Drug Delivery by Type (2012-2017)
Figure Revenue Market Share of Liposomes Drug Delivery by Type in 2016
Table United States Liposomes Drug Delivery Price (USD/Unit) by Types (2012-2017)
Figure United States Liposomes Drug Delivery Sales Growth Rate by Type (2012-2017)
Table United States Liposomes Drug Delivery Sales (K Units) by Application (2012-2017)
Table United States Liposomes Drug Delivery Sales Market Share by Application (2012-2017)
Figure United States Liposomes Drug Delivery Sales Market Share by Application (2012-2017)
Figure United States Liposomes Drug Delivery Sales Market Share by Application in 2016
Table United States Liposomes Drug Delivery Sales Growth Rate by Application (2012-2017)
Figure United States Liposomes Drug Delivery Sales Growth Rate by Application (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Liposomes Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Liposomes Drug Delivery Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Liposomes Drug Delivery Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Liposomes Drug Delivery Revenue Market Share in United States (2012-2017)
Table Gilead Sciences Basic Information List
Table Gilead Sciences Liposomes Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Gilead Sciences Liposomes Drug Delivery Sales Growth Rate (2012-2017)
Figure Gilead Sciences Liposomes Drug Delivery Sales Market Share in United States (2012-2017)
Figure Gilead Sciences Liposomes Drug Delivery Revenue Market Share in United States (2012-2017)
Table Luye Pharma Basic Information List
Table Luye Pharma Liposomes Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Luye Pharma Liposomes Drug Delivery Sales Growth Rate (2012-2017)
Figure Luye Pharma Liposomes Drug Delivery Sales Market Share in United States (2012-2017)
Figure Luye Pharma Liposomes Drug Delivery Revenue Market Share in United States (2012-2017)
Table Sun Pharmaceutical Basic Information List
Table Sun Pharmaceutical Liposomes Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sun Pharmaceutical Liposomes Drug Delivery Sales Growth Rate (2012-2017)
Figure Sun Pharmaceutical Liposomes Drug Delivery Sales Market Share in United States (2012-2017)
Figure Sun Pharmaceutical Liposomes Drug Delivery Revenue Market Share in United States (2012-2017)
Table Pacira Basic Information List
Table Pacira Liposomes Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pacira Liposomes Drug Delivery Sales Growth Rate (2012-2017)
Figure Pacira Liposomes Drug Delivery Sales Market Share in United States (2012-2017)
Figure Pacira Liposomes Drug Delivery Revenue Market Share in United States (2012-2017)
Table Fudan-Zhangjiang Basic Information List
Table Fudan-Zhangjiang Liposomes Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Fudan-Zhangjiang Liposomes Drug Delivery Sales Growth Rate (2012-2017)
Figure Fudan-Zhangjiang Liposomes Drug Delivery Sales Market Share in United States (2012-2017)
Figure Fudan-Zhangjiang Liposomes Drug Delivery Revenue Market Share in United States (2012-2017)
Table Sigma-Tau Group Basic Information List
Table Sigma-Tau Group Liposomes Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sigma-Tau Group Liposomes Drug Delivery Sales Growth Rate (2012-2017)
Figure Sigma-Tau Group Liposomes Drug Delivery Sales Market Share in United States (2012-2017)
Figure Sigma-Tau Group Liposomes Drug Delivery Revenue Market Share in United States (2012-2017)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical Liposomes Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Liposomes Drug Delivery Sales Growth Rate (2012-2017)
Figure Teva Pharmaceutical Liposomes Drug Delivery Sales Market Share in United States (2012-2017)
Figure Teva Pharmaceutical Liposomes Drug Delivery Revenue Market Share in United States (2012-2017)
Table CSPC Basic Information List
Table CSPC Liposomes Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure CSPC Liposomes Drug Delivery Sales Growth Rate (2012-2017)
Figure CSPC Liposomes Drug Delivery Sales Market Share in United States (2012-2017)
Figure CSPC Liposomes Drug Delivery Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Liposomes Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Liposomes Drug Delivery Sales Growth Rate (2012-2017)
Figure Novartis Liposomes Drug Delivery Sales Market Share in United States (2012-2017)
Figure Novartis Liposomes Drug Delivery Revenue Market Share in United States (2012-2017)
Table Crucell Basic Information List
Table Celsion Corporation Basic Information List
Table Kingond Pharm Basic Information List
Table Shanghai New Asia Basic Information List
Table Spectrum Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Liposomes Drug Delivery
Figure Manufacturing Process Analysis of Liposomes Drug Delivery
Figure Liposomes Drug Delivery Industrial Chain Analysis
Table Raw Materials Sources of Liposomes Drug Delivery Major Players/Suppliers in 2016
Table Major Buyers of Liposomes Drug Delivery
Table Distributors/Traders List
Figure United States Liposomes Drug Delivery Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Liposomes Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Liposomes Drug Delivery Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Liposomes Drug Delivery Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Liposomes Drug Delivery Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Liposomes Drug Delivery Sales Volume (K Units) Forecast by Type in 2022
Table United States Liposomes Drug Delivery Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Liposomes Drug Delivery Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Liposomes Drug Delivery Sales Volume (K Units) Forecast by Application in 2022
Table United States Liposomes Drug Delivery Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Liposomes Drug Delivery Sales Volume Share Forecast by Region (2017-2022)
Figure United States Liposomes Drug Delivery Sales Volume Share Forecast by Region (2017-2022)
Figure United States Liposomes Drug Delivery Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Polymers Drug Delivery Market Insights, Forecast to 2025
    Published: 18-Oct-2018        Price: US 3900 Onwards        Pages: 123
    In 2017, the global Polymers Drug Delivery market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Polymers Drug Delivery market based on company, product type, application and key regions. This report studies the global market size of Polymers Drug Delivery in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Afr......
  • Global Gold Nanoparticles Market Insights, Forecast to 2025
    Published: 16-Oct-2018        Price: US 3900 Onwards        Pages: 110
    This report researches the worldwide Gold Nanoparticles market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global Gold Nanoparticles breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributo......
  • 2018-2023 Global Transdermal Drug Delivery Systems Consumption Market Report
    Published: 15-Oct-2018        Price: US 4660 Onwards        Pages: 166
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Transdermal Drug Delivery Systems market for 2018-2023. Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types o......
  • Global Liposome Drug Delivery Market Insights, Forecast to 2025
    Published: 15-Oct-2018        Price: US 3900 Onwards        Pages: 119
    In 2017, the global Liposome Drug Delivery market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Liposome Drug Delivery market based on company, product type, application and key regions. This report studies the global market size of Liposome Drug Delivery in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Afr......
  • Global Topical Drug Delivery Partnering 2012-2018: Deal trends, players, financials and forecasts
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 180
    "Delivery of this report will take 1-3 days after purchase." Global Topical Drug Delivery Partnering 2012-2018 provides understanding and access to the topical drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies Topical Drug Delivery Partnering 2012-2015 report provides understanding and access to the topical drug delivery partnering deals and agreements entered into by the world's leading healthcare companies.......
  • Global Targeted Drug Delivery Partnering 2012-2018: Deal trends, players, financials and forecasts
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 170
    "Delivery of this report will take 1-3 days after purchase." Global Targeted Drug Delivery Partnering 2012-2018 report provides understanding and access to the targeted drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies Targeted Drug Delivery Partnering 2012-2018 report provides understanding and access to the targeted drug delivery partnering deals and agreements entered into by the world's leading healthcare comp......
  • Global Injectable Drug Delivery Partnering 2012-2018: Deal trends, players, financials and forecasts
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 230
    "Delivery of this report will take 1-3 days after purchase." Global Injectable Drug Delivery Partnering 2012-2018 report provides understanding and access to the injectable drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies Injectable Drug Delivery Partnering 2012-2015 report provides understanding and access to the injectable drug delivery partnering deals and agreements entered into by the world's leading healthc......
  • Global Transdermal Drug Delivery Partnering 2012-2018: Deal trends, players, financials and forecasts
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 160
    "Delivery of this report will take 1-3 days after purchase." Global Transdermal Drug Delivery Partnering 2012-2018 provides understanding and access to the transdermal drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies Transdermal Drug Delivery Partnering 2012-2018 report provides understanding and access to the transdermal drug delivery partnering deals and agreements entered into by the world's leading healthcare......
  • Global Nanotechnology Drug Delivery Market Size, Status and Forecast 2018-2025
    Published: 20-Sep-2018        Price: US 3900 Onwards        Pages: 95
    This report focuses on the global Nanotechnology Drug Delivery status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nanotechnology Drug Delivery development in United States, Europe and China. Nano-technology field has a potential to make significant impact on healthcare by delivering disease diagnosis, monitoring, implants, regenerative medicines and drug delivery, drug discovery for biomedicine. Since last few years, si......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs